EXHIBIT 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, par value NIS 5.00 per share, of Nano Dimension Ltd., and that this Agreement be included as an Exhibit to such joint filing. The Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.
IN WITNESS WHEREOF, the undersigned hereby execute this Agreement this 30th day of June, 2026.
| TANG CAPITAL MANAGEMENT, LLC | ||
| By: | /s/ Kevin Tang | |
| Kevin Tang, Manager | ||
| /s/ Kevin Tang | ||
| Kevin Tang | ||
| TANG CAPITAL PARTNERS, LP | ||
By: Tang Capital Management, LLC, its General Partner |
||
| By: | /s/ Kevin Tang | |
|
Kevin Tang, Manager |
||
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | ||
By: Tang Capital Management, LLC, its General Partner |
||
| By: | /s/ Kevin Tang | |
Kevin Tang, Manager |
||
| TANG CAPITAL PARTNERS III, INC | ||
| By: | /s/ Kevin Tang | |
| Kevin Tang, Chief Executive Officer | ||
| TANG CAPITAL PARTNERS IV, INC | ||
| By: | /s/ Kevin Tang | |
|
Kevin Tang, Chief Executive Officer |
||
|
CONCENTRA BIOSCIENCES, LLC |
||
| By: | /s/ Kevin Tang | |
|
Kevin Tang, Chief Executive Officer |
||